VitalCareUSA Business Opportunity

VitalCareUSA is not currently accepting new inquiries, please check back soon.

You can search the directory, see other Business Opportunities franchises, or see related franchises below.

VitalCareUSA

Min. Liquid Capital: $125,000

Total Investment: $80,000 - $120,000

Net Worth Required: $200,000

Financing Available: Yes

Training Provided: Yes

No of Existing Units: 10

Company-Owned Units: 4

Average Sales Last Year: $200,000



About VitalCareUSA

Join our successful diagnostic partner program and participate in the $3.4T medical industry. With projected growth reaching $5.6T by 2025, the sky is the limit. This opportunity requires very little time to run, requires no medical experience, can be semi-passive, and doesn't need additional accounting or inventory. Perfect for entrepreneurs, investors and executives who want to earn residual income while keeping their jobs.

NO Franchise Fees and NO Ongoing Franchise Royalties! This is a capital expenditure which qualifies for section IRS Code 179 tax deduction.

Why VitalCareUSA?

VitalCare offers a fully integrated Nerve Regeneration Diagnostic System which performs Electric Cell Signaling treatments for all pain, circulatory management, and rehabilitation issues. Our device conducts ​treatments for anyone with nerve damage, is highly successful with reimbursements, and extremely sought after by physicians practicing in Oncology, Podiatry, Internal Medicine, Pain Management, Orthopedics, and Neurology.

Ideal Candidate

Our program offers a turn-key passive business opportunity where you have limited or no work to run the business. The best part is you don’t need employees, inventory or accounting skills. VitalCare does everything for you. We procure the clinic site and negotiate a Fee-For-Service (FFS) Agreement with the physicians on your behalf. A total solution to allow for a seamless way to generate additional income. Let us do the work for you!

By clicking the button, you agree to BizQuest's Terms of Use and Privacy Policy.